Broad Experiences at an NCI Comprehensive Cancer Center
The ASHP-accredited specialty residency in oncology at Barnes-Jewish Hospital is designed to provide a diverse hematology and oncology experience while focusing on the needs of the individual resident. The program provides a broad experience in the numerous aspects of oncology including hematopoietic stem cell transplant, hematologic malignancies, medical oncology, gynecologic oncology, investigational drug services, pediatric oncology, palliative care, and benign hematology. Completion of a residency project is required. This PGY2 residency participates in the ASHP residency match program.
Barnes-Jewish Hospital and Washington University School of Medicine are part of the Alvin J. Siteman Cancer Center. Siteman Cancer Center (SCC) is a leader in cancer treatment, research, prevention, education and community outreach. It is the only cancer center in Missouri designated as a Comprehensive Cancer Center from the National Cancer Institute and is a member of the National Comprehensive Cancer Network. Offering more than 250 clinical trials, the SCC treats more than 8,000 new patients each year and provides follow-up care for more than 25,000 cancer survivors. Additionally, Siteman Cancer Center is one of the largest bone marrow and stem cell transplant centers in the world, averaging about 400 transplants each year and more than 5,000 transplants since the program began in 1982.
Oncology pharmacy services are provided by multiple clinical oncology pharmacy specialists on the hematopoietic stem cell transplant, hematologic malignancies, and medical oncology inpatient services and in the Siteman Cancer Center outpatient clinics. These services include participation in daily multidisciplinary rounds, patient education, staff education, and chemotherapy order evaluation. Clinical specialists assist in maintaining the continuity of care between the outpatient and inpatient setting.
- Hematologic Malignancies
- Medical Oncology
- Stem Cell Transplantation
- Investigational Drug Services
- Gynecologic Malignancies (Outpatient)
- Outpatient Oncology Clinics (Longitudinal)
- Medical Intensive Care Unit
- Benign Hematology
- Transplant Infectious Diseases
- Pediatric Oncology/Pediatric Stem Cell Transplantation
- Nutrition Support
- Palliative Care
June 27, 2016
Doctor of Pharmacy degree from an accredited school of pharmacy, successful completion of an ASHP-accredited PGY1 residency, and licensure in Missouri is required.
Number of Positions
One per year
Sara Butler, PharmD, BCOP, BCPS
Program Director, PGY2 Oncology Residency
Department of Pharmacy 90-52-411
216 S. Kingshighway Blvd.
St. Louis, MO 63110
Pictured above (left to right): PGY2 Oncology Resident, Kendall Shultes, PharmD; Stem Cell Transplant/Hematologic Malignancies Preceptor, Christopher Arp, PharmD; PGY2 Oncology Residency Program Director, Sara Butler, PharmD, BCOP, BCPS; Stem Cell Transplant/Hematologic Malignancies Preceptor, Jeffrey Klaus, PharmD, BCPS.